128 related articles for article (PubMed ID: 15520855)
1. Developing DNA vaccines that call to dendritic cells.
Kutzler MA; Weiner DB
J Clin Invest; 2004 Nov; 114(9):1241-4. PubMed ID: 15520855
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL
Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
[TBL] [Abstract][Full Text] [Related]
3. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.
Sumida SM; McKay PF; Truitt DM; Kishko MG; Arthur JC; Seaman MS; Jackson SS; Gorgone DA; Lifton MA; Letvin NL; Barouch DH
J Clin Invest; 2004 Nov; 114(9):1334-42. PubMed ID: 15520866
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
Chan T; Sami A; El-Gayed A; Guo X; Xiang J
Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor-mediated delivery of mycobacterial MPT51 protein efficiently induces antigen-specific T-cell responses.
Uchijima M; Nagata T; Koide Y
Vaccine; 2008 Sep; 26(40):5165-9. PubMed ID: 18456373
[TBL] [Abstract][Full Text] [Related]
9. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses.
Sang H; Pisarev VM; Chavez J; Robinson S; Guo Y; Hatcher L; Munger C; Talmadge CB; Solheim JC; Singh RK; Talmadge JE
Cancer Gene Ther; 2005 Apr; 12(4):427-37. PubMed ID: 15678151
[TBL] [Abstract][Full Text] [Related]
10. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
Kim JH; Majumder N; Lin H; Chen J; Falo LD; You Z
Mol Ther; 2005 Jun; 11(6):941-9. PubMed ID: 15922965
[TBL] [Abstract][Full Text] [Related]
12. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
13. Augmenting the immunogenicity of DNA vaccines: role of plasmid-encoded Flt-3 ligand, as a molecular adjuvant in genetic vaccination.
Nayak BP; Sailaja G; Jabbar AM
Virology; 2006 May; 348(2):277-88. PubMed ID: 16563456
[TBL] [Abstract][Full Text] [Related]
14. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
16. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
17. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
Chandy AG; Nurkkala M; Josefsson A; Eriksson K
Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
[TBL] [Abstract][Full Text] [Related]
19. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
20. Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.
Gustafsson K; Ingelsten M; Bergqvist L; Nyström J; Andersson B; Karlsson-Parra A
Cancer Res; 2008 Jul; 68(14):5965-71. PubMed ID: 18632652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
